Search clinical trials for: Gemcitabine + Cisplatin

Total 5660 results

Chinese University of Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Completed

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Nasopharyngeal Cancer

Hong Kong
Memorial Sloan Kettering Cancer Center
New York University; University of North Carolina, Chapel Hill

Completed

Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

Bladder Cancer

United States
University of Zurich

Completed

Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.

Cholangiocellular Carcinoma

Switzerland
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Malignant Mesothelioma

Switzerland
Julie E. Bauman, MD, MPH
Novartis

Withdrawn

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Oropharyngeal Neoplasms | Oropharyngeal Cancer | Squamous Cell Carcinoma | Carcinoma, Squamous
Zhejiang Cancer Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University; Zhejiang... and other collaborators

Unknown

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Effects of Chemotherapy | Stage IVC Nasopharyngeal Carcinoma

China
Tongji University

Unknown

Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) (BRAVO)

Non-small Cell Lung Cancer

China
University of Alabama at Birmingham

Active, not recruiting

Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) (ICC)

Cholangiocarcinoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Sun Yat-sen University

Active, not recruiting

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Nasopharyngeal Carcinoma

China
Asan Medical Center
Seoul St. Mary's Hospital; Severance Hospital; Bundang CHA Hospital

Completed

Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma

Cholangiocarcinoma | Biliary Tract Cancer | Adjuvant Chemotherapy | Capecitabine | Gemcitabine | Cisplatin

Korea, Republic of
Eli Lilly and Company

Completed

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Belgium
West China Hospital

Not yet recruiting

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
The University of Texas Health Science Center,...

Unknown

Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer (FR-WB-TT)

Pancreatic Neoplasms

United States
People's Hospital of Quzhou

Recruiting

Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Merck Sharp & Dohme LLC

Completed

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Carcinoma | Non-small Cell Lung Cancer
Shanghai Jiao Tong University School of Medicine
Shanghai 10th People's Hospital; Jiangxi Provincial Cancer Hospital; Shanghai... and other collaborators

Recruiting

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer (CCODG-NSCLC)

Recurrent Non-small Cell Lung Cancer

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma

United States
National University Hospital, Singapore

Not yet recruiting

Phase II Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Nasopharyngeal Cancer

Singapore
Sichuan Cancer Hospital and Research Institute

Unknown

Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer

Lung Cancer

China
The Christie NHS Foundation Trust

Unknown

Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin

Lung Cancer

United Kingdom
Huazhong University of Science and Technology
CSPC Ouyi Pharmaceutical Co., Ltd.

Unknown

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Biliary Tract Cancer

China
Air Force Military Medical University, China

Completed

GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China

Toxicity Due to Radiotherapy | Nasopharyngeal Squamous Cell Carcinoma

China
Samsung Medical Center

Unknown

Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression

Non-small Cell Lung Cancer

Korea, Republic of
Leap Therapeutics, Inc.

Completed

Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

Cholangiocarcinoma | Bile Duct Cancer | Carcinoma of Intrahepatic and Extra-hepatic Biliary System | Carcinoma of Gallbladder

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States, Canada
Federation Francophone de Cancerologie Digestive

Completed

Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

France
Pfizer

Terminated

Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

United States, Canada, Belgium, Italy, Spain, United Kingdom, Korea, Republic of, Netherlands, Poland, Portugal, Turkey, Taiwan, Germany, Hungary, Brazil, Hong Kong, Singapore, South Africa, China, Austria, Czech Republic, India, Is... and more
Cairo University

Completed

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

Locally Advanced Bladder Cancer

Egypt
Lahey Clinic

Withdrawn

Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

Transitional Cell Carcinoma

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence

China
University Hospital Birmingham

Unknown

Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United Kingdom
King Faisal Specialist Hospital & Research Center

Suspended

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Fudan University
Zhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University and other collaborators

Completed

Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC) (TNBC)

Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Completed

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer (CIK)

Non-small Cell Lung Cancer | Squamous Cell Carcinoma

China
Hoffmann-La Roche

Completed

A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

Urinary Tract Cancer

Germany
University College, London
AstraZeneca

Completed

Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers (ABC-03)

Biliary Tract Neoplasms

United Kingdom
NYU Langone Health
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer

Pancreatic Cancer

United States
Stichting Hemato-Oncologie voor Volwassenen Nederland
Danish Lymphoma Group

Recruiting

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission (HOVON164HL)

Hodgkin Lymphoma

Netherlands, Belgium, Denmark
Genzyme, a Sanofi Company

Completed

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

Non Small Cell Lung Cancer
Brigham and Women's Hospital

Not yet recruiting

Drug Screening Using IMD in Bladder Cancer

Muscle Invasive Bladder Urothelial Carcinoma

United States
Assiut University

Recruiting

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

Urinary Bladder Cancer

Egypt
Fifth Affiliated Hospital, Sun Yat-Sen University

Recruiting

Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

Neoadjuvant Therapy | Locally Advanced Head and Neck Squamous Cell Carcinoma

China
TerSera Therapeutics LLC

Terminated

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer (TELE-ABC)

Biliary Tract Cancer (BTC)

United States
Johannes Gutenberg University Mainz

Terminated

BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer

Metastatic Disease

Germany
Federation Francophone de Cancerologie Digestive

Completed

Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer
Assistance Publique - Hôpitaux de Paris

Terminated

Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients (GEMOXIAL)

Liver Cirrhosis | Recurrence | Carcinoma, Hepatocellular | Liver Neoplasms | Neoplasm Recurrence, Local

France
Wuhan Union Hospital, China

Unknown

Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion

Malignant Pleural Effusion

China
Merck Sharp & Dohme LLC

Completed

A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)

Solid Tumors

Search clinical trials for: Gemcitabine + Cisplatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations